Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Multiple System Atrophy

fluorodeoxyglucose f18 has been researched along with Multiple System Atrophy in 51 studies

Research

Studies (51)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (9.80)18.2507
2000's15 (29.41)29.6817
2010's21 (41.18)24.3611
2020's10 (19.61)2.80

Authors

AuthorsStudies
Eidelberg, D; Ležaić, L; Perovnik, M; Rebec, E; Rus, T; Studen, A; Tang, CC; Tomše, P; Trošt, M1
Allocca, M; Arnone, A; Berti, V; Bessi, V; De Cristofaro, MT; Di Dato, R; Ferrari, C; Laghai, I; Lombardi, G; Nerattini, M; Polito, C; Puccini, G; Ramat, S; Rubino, F; Sorbi, S1
Ahlskog, JE; Ali, F; Botha, H; Carlos, AF; Clark, HM; Coon, EA; Dickson, DW; Josephs, KA; Koga, S; Lowe, V; Pham, NTT; Sekiya, H; Trejo-Lopez, JA; Whitwell, JL1
Chen, MJ; Ge, JJ; Jiao, FY; Ju, ZZ; Li, L; Li, XY; Liang, XN; Liu, FT; Lu, JY; Luo, JF; Sun, YM; Wang, J; Wu, JJ; Wu, P; Yen, TC; Zuo, C1
Al-Fatly, B; Anton-Rodriguez, JM; Carter, SF; Gerhard, A; Herholz, K; Hinz, R; Kobylecki, C; Kübler, D; McDonald, KR; Thompson, JC1
Carli, G; de Jong, BM; Ferini-Strambi, L; Galbiati, A; Leenders, KL; Meles, SK; Padovani, A; Perani, D; Pilotto, A; Reesink, FE1
Azulay, JP; Boucekine, M; Eusebio, A; Fluchère, F; Grimaldi, S; Guedj, E; Renaud, M; Witjas, T1
Gao, S; Li, X; Zhang, B; Zhao, P1
Choi, N; Chung, SJ; Jo, S; Kim, SJ; Ko, JH; Lee, CS; Lee, EJ; Park, KW; Park, YJ1
Choi, YY; Dhawan, V; Eidelberg, D; Fahn, S; Gupta, DK; O'Shea, SA; Poston, KL; Schindlbeck, KA; Tang, CC; Vonsattel, JP1
Chung, SJ; Kim, SM; Kim, SW; Lee, PH; Lee, S; Oh, K; Shin, HY; Yoo, SK; Yun, M1
Artiko, V; Brajkovic, L; Castiglioni, I; Gallivanone, F; Jecmenica-Lukic, M; Jesic, A; Kostic, V; Odalovic, S; Radovic, B; Sobic-Saranovic, D; Stefanova, E; Stojiljkovic, M; Trajkovic, G1
Eidelberg, D; Ge, J; Guan, Y; Ma, Y; Peng, S; Wang, J; Wu, J; Wu, P; Zhang, H; Zuo, C1
Chung, SJ; Kim, J; Kim, JS; Kim, K; Kim, MJ; Kim, YJ; Lee, C; Moon, H; Oh, JS; Oh, M; Park, KW; Ryu, HS; You, S1
De Jong, BM; Dierckx, RA; Leenders, KL; Mudali, D; Renken, RJ; Roerdink, JB; Teune, LK1
Baudrexel, S; Grünwald, F; Hilker, R; Klein, JC; Middendorp, M; Penndorf, B; Seifried, C; Steinmetz, H1
Amtage, F; Buchert, R; Guschlbauer, B; Hellwig, S; Meyer, PT; Niesen, WD; Reinhard, M; Tüscher, O; Weiller, C1
Allen, PJ; Amtage, F; Eidelberg, D; Feigin, A; Hanspal, E; Heinen, L; Hellwig, S; Leenders, KL; Meyer, PT; Niethammer, M; Poston, KL; Tang, CC; Vonsattel, JP1
Choi, CG; Chung, SJ; Kim, HS; Kim, JS; Kim, SJ; Lee, CS; Oh, J; Yoon, RG1
Chung, SJ; Kim, HW; Kim, JS; Lee, CS; Lee, SJ; Oh, JS; Oh, M; Oh, SJ1
Ahn, BJ; Joo, JJ; Kwon, KY; Park, J1
Goldstein, DS; Holmes, C; Jinsmaa, Y; Kopin, IJ; Sharabi, Y; Sullivan, P1
Chung, SJ; Kim, HW; Kim, JS; Lee, SJ; Oh, JS; Oh, M; Oh, SJ1
Duan, Z; Feng, T; Li, W; Lu, L; Ouyang, Q; Wang, Y; Xiang, W1
Choi, CG; Chung, SJ; Kim, JS; Kwon, KY; Lee, MC2
Claassen, DO; Josephs, KA; Lowe, VJ; Peller, PJ; Petersen, RC1
Eun, MY; Park, KW; Seok, HY; Yu, SW1
Gao, S; Zhang, B; Zhao, P1
Goldstein, DS; Holmes, C; Sharabi, Y1
Dhawan, V; Eckert, T; Eidelberg, D; Fahn, S; Frucht, S; Poston, KL; Tang, CC; Vonsattel, JP1
Biersack, HJ; Bippus, R; Bucerius, J; Fayad, ZA; Gündisch, D; Mani, V; Manka, C; Mottaghy, FM; Rudd, JH; Schmaljohann, J; Wüllner, U1
Cooke, JP1
Amtage, F; Buchert, R; Hellwig, B; Hellwig, S; Kreft, A; Meyer, PT; Rijntjes, M; Spehl, TS; Tüscher, O; Vach, W; Weber, WA; Weiller, C; Winkler, C; Winz, OH1
Brooks, DJ; Chaudhuri, KR; Hu, MT; Jarosz, J; Yaguez, L1
Choe, B; Juh, R; Kim, J; Moon, D; Suh, T1
Choe, B; Chung, Y; Juh, R; Lee, CU; Pae, CU; Suh, T; Yang, D1
Barnes, A; Dhawan, V; Eckert, T; Eidelberg, D; Feigin, AS; Frucht, S; Gordon, MF1
Biersack, HJ; Bucerius, J; Gündisch, D; Joe, AY; Minnerop, M; Reinhardt, MJ; Schmaljohann, J; Wüllner, U1
Beuthien-Baumann, B; Donix, M; Herholz, K; Herting, B; Holthoff, VA; Lampe, JB; Pöttrich, K; Reichmann, H; Triemer, A; von Kummer, R1
Ahn, YH; Bang, OY; Huh, K; Joo, IS; Kim, JW; Lee, PH1
Jeong, Y; Lee, JH; Lee, MS; Lee, SY; Lyoo, CH; Rinne, JO; Ryu, YH; Song, TJ1
Brown, N; Eckert, T; Eidelberg, D; Feigin, A; Frucht, S; Lin, T; Ma, Y; Tang, C1
An, YS; Lee, PH; Yong, SW; Yoon, SN1
Bentho, O; Conant, S; Eldadah, BA; Goldstein, DS; Holmes, C; Imrich, R; Moak, J; Sato, T; Sharabi, Y1
Fukumura, T; Hosokawa, S; Ichiya, Y; Kato, M; Kuwabara, Y; Masuda, K; Otsuka, M; Sasaki, M; Yoshida, T1
Antonini, A; Günther, I; Leenders, KL; Maguire, RP; Missimer, J; Psylla, M; Vontobel, P1
Antonini, A; Dhawan, V; Eidelberg, D; Feigin, A; Kazumata, K; Mandel, F; Margouleff, C1
Damhaut, P; Dethy, S; Goldman, S; Hildebrand, J; Van Blercom, N; Wikler, D1
Otsuka, M; Taniwaki, T1
Jankovic, J; Kapadia, AS1

Reviews

1 review(s) available for fluorodeoxyglucose f18 and Multiple System Atrophy

ArticleYear
[Functional imaging for disorders of basal ganglia].
    Rinsho shinkeigaku = Clinical neurology, 1999, Volume: 39, Issue:1

    Topics: Basal Ganglia; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Huntington Disease; Multiple System Atrophy; Parkinson Disease; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed

1999

Trials

1 trial(s) available for fluorodeoxyglucose f18 and Multiple System Atrophy

ArticleYear
Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:5

    Topics: Brain; Disease Progression; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Mesenchymal Stem Cell Transplantation; Middle Aged; Multiple System Atrophy; Positron-Emission Tomography; Prospective Studies

2008

Other Studies

49 other study(ies) available for fluorodeoxyglucose f18 and Multiple System Atrophy

ArticleYear
Abnormal metabolic covariance patterns associated with multiple system atrophy and progressive supranuclear palsy.
    Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB), 2022, Volume: 98

    Topics: Fluorodeoxyglucose F18; Humans; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive

2022
FDG PET in the differential diagnosis of degenerative parkinsonian disorders: usefulness of voxel-based analysis in clinical practice.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022, Volume: 43, Issue:9

    Topics: Brain; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Multiple System Atrophy; Parkinsonian Disorders; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies

2022
Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy.
    Parkinsonism & related disorders, 2022, Volume: 101

    Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Levodopa; Magnetic Resonance Imaging; Multimodal Imaging; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive

2022
    Movement disorders : official journal of the Movement Disorder Society, 2022, Volume: 37, Issue:9

    Topics: Fluorodeoxyglucose F18; Humans; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Putamen; Tomography, X-Ray Computed

2022
Structural and metabolic correlates of neuropsychological profiles in multiple system atrophy and Parkinson's disease.
    Parkinsonism & related disorders, 2023, Volume: 107

    Topics: Diffusion Tensor Imaging; Fluorodeoxyglucose F18; Humans; Multiple System Atrophy; Neuropsychological Tests; Parkinson Disease; Parkinsonian Disorders

2023
Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in α-synucleinopathies.
    NeuroImage. Clinical, 2023, Volume: 39

    Topics: Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Multiple System Atrophy; Multivariate Analysis; Parkinson Disease; Positron-Emission Tomography; Synucleinopathies

2023
Multiple System Atrophy: Phenotypic spectrum approach coupled with brain 18-FDG PET.
    Parkinsonism & related disorders, 2019, Volume: 67

    Topics: Accidental Falls; Aged; Basal Ganglia Diseases; Brain; Cerebellar Diseases; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Humans; Hypotension, Orthostatic; Laryngeal Diseases; Latent Class Analysis; Male; Middle Aged; Multiple System Atrophy; Muscular Atrophy, Spinal; Pharyngeal Diseases; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals; REM Sleep Behavior Disorder; Retrospective Studies; Spinal Curvatures; Urinary Incontinence

2019
Clinical features, MRI, and 18F-FDG-PET in differential diagnosis of Parkinson disease from multiple system atrophy.
    Brain and behavior, 2020, Volume: 10, Issue:11

    Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple System Atrophy; Parkinson Disease

2020
Cortical hypometabolism associated with cognitive impairment of multiple system atrophy.
    Parkinsonism & related disorders, 2020, Volume: 81

    Topics: Aged; Cerebral Cortex; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Positron-Emission Tomography; Radiopharmaceuticals

2020
Neuropathological correlation supports automated image-based differential diagnosis in parkinsonism.
    European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:11

    Topics: Brain; Clinical Decision-Making; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Multiple System Atrophy; Parkinsonian Disorders; Uncertainty

2021
Postganglionic Sudomotor Dysfunction and Brain Glucose Hypometabolism in Patients with Multiple System Atrophy.
    Journal of Parkinson's disease, 2021, Volume: 11, Issue:3

    Topics: Brain; Fluorodeoxyglucose F18; Glucose; Humans; Multiple System Atrophy; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sympathetic Fibers, Postganglionic

2021
The utility of FDG-PET in the differential diagnosis of Parkinsonism.
    Neurological research, 2017, Volume: 39, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive

2017
Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts.
    Human brain mapping, 2018, Volume: 39, Issue:7

    Topics: Aged; Brain; Brain Mapping; China; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multiple System Atrophy; Nerve Net; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive; United States

2018
Distinct clinical features of predominant pre-synaptic and trans-synaptic nigrostriatal dysfunction in multiple system atrophy.
    Journal of the neurological sciences, 2019, Jul-15, Volume: 402

    Topics: Adult; Aged; Case-Control Studies; Cerebellar Ataxia; Corpus Striatum; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Male; Middle Aged; Multiple System Atrophy; Neural Pathways; Parkinsonian Disorders; Positron-Emission Tomography; Presynaptic Terminals; Putamen; Substantia Nigra; Tropanes

2019
Validation of parkinsonian disease-related metabolic brain patterns.
    Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:4

    Topics: Aged; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Positron-Emission Tomography; Supranuclear Palsy, Progressive

2013
The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy.
    Movement disorders : official journal of the Movement Disorder Society, 2014, Volume: 29, Issue:3

    Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Positron-Emission Tomography; Putamen

2014
Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.
    European journal of neurology, 2014, Volume: 21, Issue:6

    Topics: Aged; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Radionuclide Imaging; Sensitivity and Specificity; Supranuclear Palsy, Progressive; Ultrasonography, Doppler, Transcranial

2014
A disease-specific metabolic brain network associated with corticobasal degeneration.
    Brain : a journal of neurology, 2014, Volume: 137, Issue:Pt 11

    Topics: Aged; Aged, 80 and over; Basal Ganglia Diseases; Cerebral Cortex; Cerebrum; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolic Networks and Pathways; Middle Aged; Multiple System Atrophy; Nerve Net; Neurodegenerative Diseases; Parkinsonian Disorders; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Supranuclear Palsy, Progressive

2014
The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography.
    Neuroscience letters, 2015, Jan-01, Volume: 584

    Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Retrospective Studies

2015
Different loss of dopamine transporter according to subtype of multiple system atrophy.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:3

    Topics: Adult; Aged; Brain; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tropanes

2016
Serial MRI findings in a case of the Parkinson variant of multiple system atrophy: Clinical usefulness of diffusion-weighted imaging at B1000 in early stages of the disease.
    Journal of the neurological sciences, 2016, Mar-15, Volume: 362

    Topics: Brain Stem; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Middle Aged; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Retrospective Studies

2016
Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies.
    Parkinsonism & related disorders, 2016, Volume: 31

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Animals; Catechols; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; PC12 Cells; Putamen; Rats

2016
Striatofrontal Deafferentiation in MSA-P: Evaluation with [18F]FDG Brain PET.
    PloS one, 2017, Volume: 12, Issue:1

    Topics: Brain; Brain Mapping; Case-Control Studies; Cerebral Cortex; Corpus Striatum; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals

2017
Comparison of cerebral glucose metabolism between multiple system atrophy Parkinsonian type and Parkinson's disease.
    Neurological research, 2008, Volume: 30, Issue:4

    Topics: Adult; Aged; Biomarkers; Brain Mapping; Cerebral Cortex; Corpus Striatum; Diagnosis, Differential; Energy Metabolism; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Predictive Value of Tests; Thalamus

2008
Diagnostic value of brain MRI and 18F-FDG PET in the differentiation of Parkinsonian-type multiple system atrophy from Parkinson's disease.
    European journal of neurology, 2008, Volume: 15, Issue:10

    Topics: Adult; Aged; Cerebellum; Diffusion Magnetic Resonance Imaging; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pons; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method

2008
Amyloid and glucose imaging in dementia with Lewy bodies and multiple systems atrophy.
    Parkinsonism & related disorders, 2011, Volume: 17, Issue:3

    Topics: Aged; Amyloid; Aniline Compounds; Brain Mapping; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lewy Body Disease; Male; Middle Aged; Multiple System Atrophy; Positron-Emission Tomography; Thiazoles; Tomography, X-Ray Computed

2011
FDG-PET and MRI features in multiple system atrophy.
    Acta neurologica Belgica, 2011, Volume: 111, Issue:1

    Topics: Aged; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multiple System Atrophy; Positron-Emission Tomography

2011
18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes.
    Parkinsonism & related disorders, 2012, Volume: 18 Suppl 1

    Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Supranuclear Palsy, Progressive; Syndrome

2012
Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies.
    Brain : a journal of neurology, 2012, Volume: 135, Issue:Pt 6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Biomarkers; Catecholamines; Dopamine Agents; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Positron-Emission Tomography; Pure Autonomic Failure; ROC Curve

2012
Network correlates of disease severity in multiple system atrophy.
    Neurology, 2012, Apr-17, Volume: 78, Issue:16

    Topics: Biomarkers; Brain; Case-Control Studies; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Male; Middle Aged; Models, Statistical; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Severity of Illness Index

2012
Feasibility of [18F]-2-Fluoro-A85380-PET imaging of human vascular nicotinic acetylcholine receptors in vivo.
    JACC. Cardiovascular imaging, 2012, Volume: 5, Issue:5

    Topics: Aged; Aged, 80 and over; Aorta, Thoracic; Azetidines; Carotid Arteries; Case-Control Studies; Feasibility Studies; Female; Fluorodeoxyglucose F18; Germany; Humans; Male; Middle Aged; Multimodal Imaging; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Receptors, Nicotinic; Tomography, X-Ray Computed

2012
Imaging vascular nicotine receptors: a new window onto vascular disease.
    JACC. Cardiovascular imaging, 2012, Volume: 5, Issue:5

    Topics: Aorta, Thoracic; Azetidines; Carotid Arteries; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Receptors, Nicotinic; Tomography, X-Ray Computed

2012
[¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
    Neurology, 2012, Sep-25, Volume: 79, Issue:13

    Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodobenzenes; Lewy Body Disease; Male; Middle Aged; Multiple System Atrophy; Neurodegenerative Diseases; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon

2012
An imaging study of parkinsonism among African-Caribbean and Indian London communities.
    Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:6

    Topics: Adult; Aged; Black People; Brain; Cerebral Cortex; Corpus Striatum; Cross-Cultural Comparison; Diagnosis, Differential; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; India; Lewy Body Disease; London; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Neuropsychological Tests; Parkinsonian Disorders; Radiography; Radionuclide Imaging; Supranuclear Palsy, Progressive; West Indies; White People

2002
Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
    European journal of radiology, 2004, Volume: 51, Issue:3

    Topics: Aged; Brain; Case-Control Studies; Caudate Nucleus; Cerebellum; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Male; Mesencephalon; Middle Aged; Multiple System Atrophy; Neocortex; Parkinson Disease; Parkinsonian Disorders; Pons; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Retrospective Studies; Supranuclear Palsy, Progressive; Thalamus

2004
Voxel based comparison of glucose metabolism in the differential diagnosis of the multiple system atrophy using statistical parametric mapping.
    Neuroscience research, 2005, Volume: 52, Issue:3

    Topics: Aged; Aged, 80 and over; Brain; Brain Mapping; Case-Control Studies; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals

2005
FDG PET in the differential diagnosis of parkinsonian disorders.
    NeuroImage, 2005, Jul-01, Volume: 26, Issue:3

    Topics: Aged; Aging; Brain; Brain Mapping; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multiple System Atrophy; Nerve Degeneration; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive

2005
Feasibility of 2-deoxy-2-[18F]fluoro-D-glucose- A85380-PET for imaging of human cardiac nicotinic acetylcholine receptors in vivo.
    Clinical research in cardiology : official journal of the German Cardiac Society, 2006, Volume: 95, Issue:2

    Topics: Aged; Feasibility Studies; Female; Fluorodeoxyglucose F18; Heart; Heart Ventricles; Humans; Male; Middle Aged; Multiple System Atrophy; Myocardium; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Nicotinic

2006
Prefrontal cortex dysfunction and depression in atypical parkinsonian syndromes.
    Movement disorders : official journal of the Movement Disorder Society, 2007, Mar-15, Volume: 22, Issue:4

    Topics: Aged; Brain Stem; Cerebellum; Cognition Disorders; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Neuropsychological Tests; Parietal Lobe; Parkinsonian Disorders; Pilot Projects; Positron-Emission Tomography; Prefrontal Cortex; Radiopharmaceuticals; Severity of Illness Index; Thalamus; Tomography, X-Ray Computed

2007
Comparison of brain MRI and 18F-FDG PET in the differential diagnosis of multiple system atrophy from Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2007, Volume: 22, Issue:16

    Topics: Aged; Brain; Brain Mapping; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies

2007
Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy.
    Brain : a journal of neurology, 2008, Volume: 131, Issue:Pt 2

    Topics: Aged; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Neuropsychological Tests; Parkinson Disease, Secondary; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors

2008
Abnormal metabolic networks in atypical parkinsonism.
    Movement disorders : official journal of the Movement Disorder Society, 2008, Apr-15, Volume: 23, Issue:5

    Topics: Aged; Brain Stem; Cerebellum; Cohort Studies; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Middle Aged; Multiple System Atrophy; Nerve Net; Parkinsonian Disorders; Positron-Emission Tomography; Putamen; Reference Values; Reproducibility of Results; Supranuclear Palsy, Progressive

2008
Cortical metabolic changes in the cerebellar variant of multiple system atrophy: a voxel-based FDG-PET study in 41 patients.
    NeuroImage, 2008, Apr-01, Volume: 40, Issue:2

    Topics: Cerebellum; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Positron-Emission Tomography; Radiopharmaceuticals

2008
Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy.
    Parkinsonism & related disorders, 2008, Volume: 14, Issue:8

    Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Biomarkers; Brain; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Septum; Humans; Male; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Sensitivity and Specificity

2008
Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomography with 18F-dopa and 18F-FDG.
    Annals of nuclear medicine, 1997, Volume: 11, Issue:3

    Topics: Adult; Aged; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Tomography, Emission-Computed

1997
Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease.
    Brain : a journal of neurology, 1997, Volume: 120 ( Pt 12)

    Topics: Aged; Carbon Radioisotopes; Caudate Nucleus; Corpus Striatum; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hypotension, Orthostatic; Male; Middle Aged; Multiple System Atrophy; Neurons; Parkinson Disease; Putamen; Raclopride; Radiography; Radiopharmaceuticals; Receptors, Dopamine D2; Regression Analysis; Salicylamides; Tomography, Emission-Computed

1997
Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET.
    Movement disorders : official journal of the Movement Disorder Society, 1998, Volume: 13, Issue:2

    Topics: Aged; Blood Glucose; Brain Mapping; Diagnosis, Differential; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Parkinson Disease, Secondary; Tomography, Emission-Computed

1998
Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism.
    Movement disorders : official journal of the Movement Disorder Society, 1998, Volume: 13, Issue:2

    Topics: Adult; Aged; Antiparkinson Agents; Basal Ganglia; Blood Glucose; Brain Mapping; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Levodopa; Male; Middle Aged; Motor Skills; Multiple System Atrophy; Neurologic Examination; Parkinson Disease; Tomography, Emission-Computed; Treatment Outcome

1998
Functional decline in Parkinson disease.
    Archives of neurology, 2001, Volume: 58, Issue:10

    Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Demography; Dihydroxyphenylalanine; Disease Progression; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Multiple System Atrophy; Multivariate Analysis; Neurologic Examination; Parkinson Disease; Radiopharmaceuticals; Time Factors

2001